CWlR serves on advisory boards of Novo Nordisk A/S, Herbalife, GI Dynamics, Eli Lilly and Company, Johnson & Johnson, Glia, and Boehringer Ingelheim and was gifted stockholdings in September 2021 and divested all stock holdings in Keyron in September 2021
| DOI: 10.1097/CXA.0000000000000061 Center for Disease Control and Prevention
These changes interact with sleep in important ways that deserve attention for optimal results
Interest has focused on substances with antioxidant potential such as: vitamin E, carotenes, flavonoids, resveratrol, epigallocatechin gallate, curcumin, Co-enzyme Q10, melatonin and edaravone as useful agents in the management of this disease (Table 1)
it is a documented range, and the research literature has not established an optimal daily frequency for any human goal